| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 115,538 | 102,722 | 68,487 | 74,689 | | Cost of Revenue | 59,844 | 54,312 | 35,998 | 36,413 | | | Gross Profit | 55,694 | 48,410 | 32,489 | 38,276 | | | Operating Expenses | | Research Development | 28,207 | 27,476 | 29,547 | 30,342 | | Selling General and Administrative | 23,100 | 36,852 | 24,612 | 21,010 | | Non Recurring |
-
|
-
|
-
| (22,987) | | Others | 109 | 109 | 109 | 23,096 | | | | Total Operating Expenses |
-
|
-
|
-
| 51,461 | | | | Operating Income or Loss | 4,278 | (16,027) | (21,779) | (13,185) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,748 | 2,183 | 3,452 | 2,925 | | Earnings Before Interest And Taxes | 6,026 | (13,844) | (18,327) | (10,260) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 6,026 | (13,844) | (18,327) | (10,260) | | Income Tax Expense | 1,150 |
-
| 2,740 | 9,949 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,876 | (13,844) | (21,067) | (20,209) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,876 | (13,844) | (21,067) | (20,209) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,876 | ($13,844) | ($21,067) | ($20,209) |
|
0.51% Nasdaq 
Income Statement
